Timothy Daley
Stock Analyst at Wells Fargo
(2.03)
# 3,031
Out of 5,154 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $44.55 | -0.20% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $5.15 | +288.35% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $91.34 | +4.01% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $36.68 | +96.29% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $115.07 | +26.01% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,209.65 | +7.47% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $302.54 | -5.80% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $195.50 | +26.34% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $174.46 | +57.63% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $269.67 | +0.12% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $9.70 | +188.66% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $15.41 | +127.13% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $501.97 | +3.59% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.37 | +2,338.36% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $119.99 | +54.18% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $75.74 | +12.23% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $174.49 | +26.08% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $107.20 | +105.22% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $8.17 | +242.72% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $199.21 | -29.72% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $53.89 | +67.01% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $44.55
Upside: -0.20%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $5.15
Upside: +288.35%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $91.34
Upside: +4.01%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $36.68
Upside: +96.29%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $115.07
Upside: +26.01%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,209.65
Upside: +7.47%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $302.54
Upside: -5.80%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $195.50
Upside: +26.34%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $174.46
Upside: +57.63%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $269.67
Upside: +0.12%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $9.70
Upside: +188.66%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $15.41
Upside: +127.13%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $501.97
Upside: +3.59%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.37
Upside: +2,338.36%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $119.99
Upside: +54.18%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $75.74
Upside: +12.23%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $174.49
Upside: +26.08%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $107.20
Upside: +105.22%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $8.17
Upside: +242.72%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $199.21
Upside: -29.72%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $53.89
Upside: +67.01%